Holen Sie sich die Stockscreener-App
1.67
2.45%
0.04
Schlusskurs vom Vortag:
$1.63
Offen:
$1.62
24-Stunden-Volumen:
459.82K
Relative Volume:
0.75
Marktkapitalisierung:
$223.82M
Einnahmen:
$108.81M
Nettoeinkommen (Verlust:
$-186.70M
KGV:
-1.9834
EPS:
-0.842
Netto-Cashflow:
$-16.83M
1W Leistung:
-0.60%
1M Leistung:
+1.21%
6M Leistung:
+16.78%
1J Leistung:
+8.44%
1-Tages-Spanne:
$1.61
$1.67
1-Wochen-Bereich:
$1.61
$1.72
52-Wochen-Spanne:
$0.85
$2.0787
Organigram Global Inc Stock (OGI) Company Profile
Vergleichen Sie OGI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.67 | 218.46M | 108.81M | -186.70M | -16.83M | -0.842 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-17 | Fortgesetzt | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-12 | Hochstufung | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | Hochstufung | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-01-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Underperform |
| 2020-01-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-11 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Organigram Global Inc Aktie (OGI) Neueste Nachrichten
Organigram Global (OGI) Projected to Post Earnings on Tuesday - MarketBeat
Organigram Inc. Names James Yamanaka as CEO - Prepared Foods
Is Organigram Global Stock Built to Withstand a Pullback? - Trefis
Is Organigram Global Inc a good long term investmentHealthcare Stock Analysis & Low Cost Wealth Building - earlytimes.in
Stocks in play: Organigram Global Inc. - The Globe and Mail
Organigram to Announce Q4 2025 Earnings on December 16 - TipRanks
Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025 - The Globe and Mail
Will Organigram Global Inc. (0OG) stock test record highs in 20252025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
How Organigram Global Inc. stock reacts to job market dataWeekly Trend Summary & Target Return Focused Picks - Newser
Organigram Appoints New CEO to Drive Global Growth - TipRanks
Will Organigram Global Inc. (0OG) stock beat growth indexes2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Is Organigram Global Inc. (0OG) stock overpriced at current multiplesShort Setup & Technical Analysis for Trade Confirmation - Newser
Top Cannabis Stocks Worth WatchingNovember 29th - MarketBeat
OGI (Organigram Global) EV-to-EBITDA : -388.57 (As of Dec. 02, 2025) - GuruFocus
Will Organigram Global Inc. (0OG) stock gain from lower interest ratesWeekly Profit Analysis & Long-Term Safe Investment Plans - Newser
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Organigram upgrades lighting, premier ponders adding cannabis to interprovincial trade deal - CBC
James Yamanaka Named CEO of Organigram - mg Magazine
Organigram aims to boost crop yields, productivity with government support - StratCann
Organigram taps James Yamanaka as CEO - MSN
[6-K] ORGANIGRAM GLOBAL INC. Current Report (Foreign Issuer) | OGI SEC FilingForm 6-K - Stock Titan
Organigram Announces Appointment Of Chief Executive Officer >OGI.T - 富途牛牛
Organigram appoints former BAT executive as new CEO By Investing.com - Investing.com Nigeria
Organigram Global Inc. Appoints Peter Amirault as Executive Chair, Effective from December 1, 2025 - marketscreener.com
Organigram Announces Appointment of James Yamanaka as Chief Executive Officer, Effective on or About January 15, 2026 - MarketScreener
BTI Executive James Yamanaka to Lead Organigram Global as New CE - GuruFocus
Organigram appoints former BAT executive as new CEO - Investing.com India
Organigram Announces Appointment of Chief Executive Officer - marketscreener.com
Sell Village Farms And Buy Organigram (NASDAQ:OGI) - Seeking Alpha
Cannabis Stocks To ResearchNovember 19th - MarketBeat
How Organigram Global Inc. stock performs in weak economyDividend Hike & Technical Buy Zone Confirmation - newser.com
Will Organigram Global Inc. stock benefit from sector rotationJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
Ranking Organigram Global Inc. among high performing stocks via toolsJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Is Organigram Global Inc. (0OG) stock considered safe havenGap Down & Fast Entry and Exit Trade Plans - newser.com
Why analysts upgrade Organigram Global Inc. stockEarnings Performance Report & Low Volatility Stock Recommendations - newser.com
Does Organigram Global Inc. qualify in momentum factor screening2025 Market Trends & Long Hold Capital Preservation Plans - newser.com
Published on: 2025-11-20 00:57:32 - newser.com
Why Organigram Global Inc. stock is considered a top pickAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Can Organigram Global Inc. (0OG) stock resist broad market declines2025 Risk Factors & Growth Focused Investment Plans - newser.com
Finanzdaten der Organigram Global Inc-Aktie (OGI)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.87%
4.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):